...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel 4-aryl-pyrido(1,2-c)pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.
【24h】

Novel 4-aryl-pyrido(1,2-c)pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.

机译:

获取原文
获取原文并翻译 | 示例
           

摘要

A number of 4-aryl-5,6,7,8-tetrahydropyrido1,2-cpyrimidine with 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indole or 2-methyl-3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indole residues were synthesized for further investigation of SAR in a group of pyrido1,2-cpyrimidine derivatives with dual 5-HT(1A)/SERT activity. Compounds 8a-8p were found to be potent ligands for both 5-HT(1A) and SERT with K(i) ranging from 28,3 to 642 nM and 42,4 nM-1,8 muM, respectively. Moreover compounds 8a, 8b, 8c, 8d, 8e and 8g were found to be selective agonists, while 8i as an antagonist of 5-HT(1A) presynaptic receptors in the inducible hypothermia test in mice.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号